SADLER AND CASTRO (1976) reported that a single dose of C. parvum vaccine given i.p. or i.v. before excision of subcutaneous transplants of Lewis lung carcinoma in C57 BL mice (the strain of origin) significantly reduced the incidence of lung metastases 21 days after transplantation of tumour. The vaccine was most effective when given 3-4 days before operation. Since Lewis lung carcinoma arose as long ago as 1951, it was possible that the effectiveness of the vaccine using this system had depended upon a minor degree of artefactual tumour immunogenicity imposed by genetic divergence between the mouse in which the tumour arose and the recipient mice used by Sadler and Castro (1976) . These authors suggested to us that it would be of interest to attempt to reproduce their findings in simulated experiments using transplanted tumour systems, available to us, in which the intromission of artefactual tumour immunogenicity is far less likely. The variety of sites and the wide range of time in which secondary disease was manifested using our systems made the presentation of our data necessarily more complex than that possible for Sadler and Castro (1976) .
Nevertheless, we believe that our assessment of the incidence of secondary disease has been sufficiently comprehensive to allow equal consideration of our data as evidence bearing on the general question whether preoperative administration of C. parvum vaccine can reduce or delay the development of secondary disease.
MATERIALS AND METHODS
Mice and tumours.-CBA Carcinoma NT (Hewitt) is a poorly differentiated adenocarcinoma which arose spontaneously in 1968 in a female of our colony of CBA/Ht mice. We have previously published data for the sites and times of manifestation of secondary disease in mice which had had intradermal transplants of this tumour excised (Hewitt, 1976; Hewitt and Blake, 1977a) .
WHT Carcinoma N-C (Hewitt) is a moderately well-differentiated adenocarcinoma which arose spontaneously in a female of our colony of WHT/Ht mice in 1974.
Both tumours arose in subcutaneous sites, and may be assumed to be of mammary origin; they have been maintained by serial s.c. transplantation in mice of the strain of origin, and in the present experiments were transplanted to 2-4-month-old females. From the results of putative, specific, activeimmunization studies, using fully quantitative challenge assays for testing "immunized" mice, we have shown that neither tumour is immunogenic in the mouse strain of origin.
Transplantation and excision of tumours.-Suspensions of viable tumour cells were prepared from solid tumours by multiple successive digestions of tumour mince using trypsin and pancreatin (Hewitt, 1966) ; the larger clumps of cells remaining after digestion were allowed to fall out of the suspensions during a short period of sedimentation under gravity. The density of morphologically intact tumour cells in the supernate was determined by counting under phase-contrast microscopy and expressed as cells per 20 mm3. Batches of mice to receive transplanted tumours were injected with a specified number of tumour cells in 20 mm3 of Tyrode solution containing 5% mouse serum. Injections were given intradermally (i.d.) under ether anaesthesia in a site near the costal margin in the anterior axillary line on the left side. The resulting tumours were simply excised under ether anaesthesia by removing an ellipse of skin bearing the tumour and extending 2-4 mm beyond it; wounds were closed with 3 metal clips which were removed 5-6 days later. Excised tumours were weighed individually after trimming away the margin of free skin.
Corynebacterium parvum vaccine.-Mice to receive vaccine were injected i.p. with 0.1 ml of "Coparvax" (Wellcome Reagents Ltd) 4 days before excision of tumours, this being the optimum time for effectiveness of the vaccine in the experiments of Sadler and Castro (1976) . In a preliminary study of the effect of this dose of vaccine on normal mice, we observed that the mice remained hunched and quiet for some hours after injection; slight lymphopenia and anaemia were evident by the 10th day; marked splenomegaly and hepatomegaly were present on the 21st day, and had not entirely resolved by the 77th day. Assessment of secondary disease in operated mice.-Mice were examined every 2-3 days after operation. Recurrence near the site of excision, and regional nodal metastasis in the axilla, were detected by palpation, and mice were killed and dissected within the next few days, after progressive growth of tumour in these sites had been confirmed; a record was made of the number of metastatic nodules visible on the surface of the lungs and of the presence of metastasis in any other viscera (although individual nodules were counted on lungs, metastasis in other organs was recorded as one for each organ affected). Mice whose first manifestation of secondary disease was due to visceral metastasis, presented with slight general sickness; these were killed and dissected at the first signs of sickness, and the total number of metastases was recorded as above. Although this mode of assessment gave a spread of times after operation at which counts were made, we have accounted this in our results by recording the mean times of examination for the vaccinated and unvaccinated groups of mice in each experiment.
EXPERIMENTS AND RESULTS

CBA Carcinoma NT
All mice of a batch of 40 which had received single i.d. inocula of 56,000 viable tumours cells on Day 0 had developed tumours by Day 17, and on this day they were segregated into 2 equal groups; one group received C. parvum vaccine i.p. and the other received no injection. On Day 21, 4 days after vaccination, mice of both groups had their tumours excised, after which they were observed for manifestations of secondary disease. One mouse of each group was lost during anaesthesia. The experiment was terminated on Day 123, 48 days after the last mouse presented with signs of disease. Surviving mice were killed and found to be free from macroscopic signs of disease.
The results of the experiment are Table I , which shows that, although the mean weight of the excised tumours was smaller in the vaccinated than in the unvaccinated mice, there was no significant difference between the 2 groups in respect of: the incidence or mean time of presentation at any of the different sites of secondary disease; the mean number of metastases per mouse; or the mean time at which the mice were killed and the counts made. Fewer of the vaccinated than of the unvaccinated mice survived without disease to the end of the period of observation, but this difference is not significant. Additionally, we have compared the incidences and latent periods of the 3 forms of presentation of secondary disease in the vaccinated mice with the corresponding pooled values for 193 unvaccinated, operated mice observed in previous metastasis studies of this tumour (Hewitt and Blake, 1977a Table II , in the same form as for the similar experiment with the CBA carcinoma. It is seen that there is no significant difference in the incidence or mean time of presentation of the various categories of secondary disease, in the mean number of metastases per mouse, or in the survival rate at the end of the observation period. One mouse of the unvaccinated group died under anaesthesia during the operation for excision.
Thus, the results of the experiments using the 2 carcinomas failed to reveal any influence of the single dose of C. parvum vaccine on the course of secondary disease. We have thus been unable to confirm the results of Sadler and Castro (1976) , who used the Lewis lung carcinoma, although we had imitated their conditions as closely as the intrinsic differences between the tumour systems allowed.
DISCUSSION
Our failure to demonstrate that C. parvum vaccine given before excision of tumours had a restraining influence on the development of secondary disease in the operated mice conforms to our expectations for tumours of the status of those used. We have reported elsewhere ) that we were unable to demonstrate immunogenicity in any of 7 transplanted murine tumours we have examined. Mice were subjected to putative, specific, active immunization by multiple injections of lethally irradiated cells. Viable homologous tumour cells were then assayed in parallel in the putatively immunized and in untreated mice. The number of viable tumour cells required to give rise to tumours in 50 % of mice was in no case higher in the immunized than in the untreated mice. We attribute our uniform failure to demonstrate immunogenicity to the status of the systems we have in-variably used; all have been ofspontaneous origin in our own inbred colonies of mice and have been isogeneically transplanted within the same colonies.
Since C. parvum vaccine, used in relation to tumours, is considered to be a nonspecific stimulator (or moderator) of immune responsiveness, there is no reason to believe that it would have an effect on transplanted systems in which immunogenicity cannot be demonstrated by specific immunization. We are not aware of any evidence that the bacteria can superimpose specific antigenicity on tumour cells.
The most likely explanation for our failure to confirm the findings of Sadler and Castro (1976) lies in the comparative status of the transplanted tumour systems used, in respect of their liability to superimposed artefactual immunogenicity. Although the Lewis lung carcinoma is of spontaneous origin, its 25-year history of transplantation and inter-laboratory transfer imply that any contemporary transplant system by which it is represented has been exposed to very large opportunities for the acquisition of artefactual immunogenicity. We refer not only to the considerable risk of genetic diversity between the substrain of origin (C57BL) and the recipients used by Sadler and Castro (C57BL/10 Sc Sn) but to the risk of contamination of the tumour by oncoviruses or non-oncogenic viruses, in one or more of the laboratories in which the tumour has resided. It is known that such accidental infection can confer permanent immunogenicity on a tissue (independently of the survival of infective virus in it) when it is transplanted to nominally isogeneic mice not tolerant to the infective agent (Svet-Moldavsky et al., 1970; Fieldsteel et al., 1973; Kobayashi et al., 1969) . The systems we have used here are only 10 and 4 years from their times of origin and have been maintained in a laboratory to which no viruses have been deliberately imported.
Our systems are distinguished from the Lewis lung carcinoma system by their multiform expression of secondary disease. Whereas only pulmonary metastases were observed in the experiments of Sadler and Castro (1976) , we encountered significant incidences of nodal metastasis and local recurrence in our operated mice. The relatively high incidences of local recurrence (16% for the CBA tumour and 51% for the WHT tumour) are not in our view the reflection of inadequate surgery, in the sense of excision through tumour. The margin of tumour-free skin was always generous and we have encountered a high rate of recurrence even when very early dermal tumours have been excised exceptionally widely. For the following reasons we believe that our recurrences arise from tumour cells which have been disseminated into lymphatics: we have shown previously (Hewitt and Blake, 1977b) that, in the case of all of 6 tumours investigated, there is a continuous flow of viable tumour cells through the regional nodes; our recurrences were nearly all sited at or beyond the cephalic end of our longitudinal elliptical incisions, in a direction towards the regional (axillary) nodes; in unpublished experiments with CBA Carcinoma NT we have observed that tumours commonly arise at the site oftight ligatures inserted between the tumours and the axillary nodes during tumour growth. Our conclusion is that the effect of surgery is either to release tumour cells from lymphatics at the site of their transection, or to produce stasis of lymphatic flow (with encouragement of endothelial adherence and growth of tumour cells) beyond the wound. A similar explanation is commonly given for the high recurrence rate after local excision of clinical malignant melanomas. Sadler and Castro (1976) 
